JCAD polymorphisms have also been linked to pulmonary emphysema [19], Alzheimer’s disease [20], ovarian tumors [21], and progression of nonalcoholic steatohepatitis to hepatocellular carcinoma [22]. This evidence concerns the gene JCAD and metabolic dysfunction-associated steatohepatitis.